Equity
AbbVie·Balance Sheet Statement·8 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $141.9B | $143.4B | $135.2B | $136.2B | $137.2B | $133.9B | $134.0B | $136.5B |
| Additional paid-in capital | $20.9B | $21.2B | $21.3B | $21.8B | $22.0B | $22.3B | $22.5B | $23.0B |
| Retained earnings | -$3.8B | -$5.0B | -$7.9B | -$9.5B | -$11.5B | -$14.2B | -$15.5B | -$17.9B |
| Treasury Stock, Value | $7.8B | $7.8B | $8.2B | $9.1B | $9.1B | $9.1B | $9.1B | $10.6B |
| Total stockholders' equity | $6.8B | $6.0B | $3.3B | $1.4B | -$183.0M | -$2.6B | -$3.3B | -$6.7B |
| Share Repurchase Program - Amount Remaining | $3.9B | $3.9B | — | $2.9B | $2.9B | $2.9B | — | $1.8B |
| Accumulated other comprehensive income (loss) | -$2.5B | -$2.3B | -$1.9B | -$1.7B | -$1.5B | -$1.6B | -$1.1B | -$1.2B |
| Common stock | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M |